BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11121508)

  • 21. Retroviral bicistronic vectors.
    Pfützner W
    Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety features of retroviral vectors.
    Hansen AC; Pedersen FS
    Curr Opin Mol Ther; 2002 Aug; 4(4):324-33. PubMed ID: 12222870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reticuloendotheliosis viruses and derived vectors.
    Dornburg R
    Gene Ther; 1995 Jul; 2(5):301-10. PubMed ID: 7671105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting retrovirus entry.
    Cosset FL; Russell SJ
    Gene Ther; 1996 Nov; 3(11):946-56. PubMed ID: 8940634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral vectors: new applications for an old tool.
    Barquinero J; Eixarch H; Pérez-Melgosa M
    Gene Ther; 2004 Oct; 11 Suppl 1():S3-9. PubMed ID: 15454951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
    Blesch A
    Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting retroviral vector function and structural integrity.
    McLachlin JR; Mittereder N; Daucher MB; Kadan M; Eglitis MA
    Virology; 1993 Jul; 195(1):1-5. PubMed ID: 8391178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
    Dupont F; Karim A; Dumon JC; Mine N; Avalosse B
    Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
    Werner M; Kraunus J; Baum C; Brocker T
    Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction to viral vectors.
    Warnock JN; Daigre C; Al-Rubeai M
    Methods Mol Biol; 2011; 737():1-25. PubMed ID: 21590391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cell cycle status on early events in retroviral replication.
    Katz RA; Greger JG; Skalka AM
    J Cell Biochem; 2005 Apr; 94(5):880-9. PubMed ID: 15669021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [General principles of the production and use of retroviral vectors].
    Lehn P
    Pathol Biol (Paris); 1993 Oct; 41(8):658-62. PubMed ID: 8290308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral vector-mediated gene expression in hematopoietic cells.
    Baum C; Richters A; Ostertag W
    Curr Opin Mol Ther; 1999 Oct; 1(5):605-12. PubMed ID: 11249667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retroviral targeted delivery.
    Schnierle BS; Groner B
    Gene Ther; 1996 Dec; 3(12):1069-73. PubMed ID: 8986432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vectors and delivery systems in gene therapy.
    Gardlík R; Pálffy R; Hodosy J; Lukács J; Turna J; Celec P
    Med Sci Monit; 2005 Apr; 11(4):RA110-21. PubMed ID: 15795707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SV40-based gene therapy vectors: turning an adversary into a friend.
    Strayer DS
    Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral vectors: a wide range of choices and high levels of service.
    Osten P; Grinevich V; Cetin A
    Handb Exp Pharmacol; 2007; (178):177-202. PubMed ID: 17203656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.